Deep Vein Thrombosis in Intensive Care.

Area of Science:

• Critical Care Medicine
• Cardiovascular Medicine
• Hematology

Background:

• Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a severe complication in critically ill patients, often linked to multiorgan dysfunction and prolonged immobilization.
• VTE prophylaxis is a standard for hospital accreditation, yet VTE incidence in intensive care units (ICUs) ranges from 5-15% despite prophylaxis.
• ICU patient risk for VTE and bleeding fluctuates daily due to various clinical factors, necessitating patient-centered risk assessment.

Purpose of the Study:

• To highlight the dynamic nature of VTE and bleeding risks in ICU patients.
• To emphasize the need for individualized thromboprophylaxis strategies.
• To discuss current diagnostic and prophylactic approaches for VTE in the ICU setting.

Main Methods:

• Review of current guidelines and evidence regarding VTE prophylaxis in ICUs.
• Discussion of patient-centered risk assessment incorporating pre-existing factors, diagnoses, and treatments.
• Emphasis on imaging-based diagnosis (ultrasound) for DVT and consideration of mechanical prophylaxis.

Main Results:

• Current consensus supports heparin use for prophylaxis upon ICU admission, with temporary suspension for active bleeding or severe thrombocytopenia.
• Individualized thromboprophylaxis regimens have been proposed but lack definitive evidence-based consensus.
• Imaging-based diagnosis is essential for DVT, with weekly ultrasound screening recommended to monitor incidence throughout ICU stay.

Conclusions:

• ICU patients require dynamic, individualized VTE risk assessment and management.
• Standardized DVT diagnosis via ultrasound screening is crucial for monitoring and improving prophylaxis effectiveness.
• The ICU remains a critical area requiring further research and development in VTE prophylaxis strategies.